Nancy Thornberry sold $262K of DNLI stock

Nancy Thornberry, Dir of Denali Therapeutics Inc. (DNLI), sold 11,439 shares of DNLI stock worth $262K, per an SEC Form 4 filed Sep 4, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 2, 2026, 2 days before it was made public.

DNLI has moved -17.3% since the trade date, from $22.85 to $18.89 (Nov 12, 2026 close).